Download - Malaria - Year 3 - 2009-10 Rumala
![Page 1: Malaria - Year 3 - 2009-10 Rumala](https://reader034.vdocument.in/reader034/viewer/2022051108/545dc78eb1af9f2d0a8b4dc0/html5/thumbnails/1.jpg)
MALARIA – Pathophysiology, Clinical features, Management & Epidemiology
Rumala MorelDepartment of ParasitologyUniversity of Peradeniya Y3S2
![Page 2: Malaria - Year 3 - 2009-10 Rumala](https://reader034.vdocument.in/reader034/viewer/2022051108/545dc78eb1af9f2d0a8b4dc0/html5/thumbnails/2.jpg)
Objectives• Name the parasites causing human malaria worldwide
indicating those present in Sri Lanka.
• Describe the life cycle - recapitulation
• Describe the pathological and clinical consequences of the erythrocytic cycle including relapse & recrudescence
• Malaria diagnosis - recapitulation
• Name the anti malarial drugs in common use and describe the mode of action of each – recapitulation
• Describe the current malaria situation in Sri Lanka• Describe the preventive and control measures used by
Anti Malaria Campaign in Sri Lanka
![Page 3: Malaria - Year 3 - 2009-10 Rumala](https://reader034.vdocument.in/reader034/viewer/2022051108/545dc78eb1af9f2d0a8b4dc0/html5/thumbnails/3.jpg)
World map of current malaria incidence
2.4 Billion Population at risk
1 million children die every year
![Page 4: Malaria - Year 3 - 2009-10 Rumala](https://reader034.vdocument.in/reader034/viewer/2022051108/545dc78eb1af9f2d0a8b4dc0/html5/thumbnails/4.jpg)
![Page 5: Malaria - Year 3 - 2009-10 Rumala](https://reader034.vdocument.in/reader034/viewer/2022051108/545dc78eb1af9f2d0a8b4dc0/html5/thumbnails/5.jpg)
5 Plasmodium spp. causing HUMAN MALARIA
3. P.malariae band form
1. P.falciparum small rings
2. P.vivax large rings & schizonts
4. P.ovale red cell has oval shape
Found in SL Not in SL
Common Species worldwide
5. P.knowlesiMonkey parasite.Human diseaseSouth-East Asia
![Page 6: Malaria - Year 3 - 2009-10 Rumala](https://reader034.vdocument.in/reader034/viewer/2022051108/545dc78eb1af9f2d0a8b4dc0/html5/thumbnails/6.jpg)
5th Human Malaria ParasitePlasmodium knowlesi
Rapidly multiply –
Quotidian 24h Erythrocytic cycle
Early Trophozoites: small rings similar to
P.falciparum
Late Trophozoites :band-forms like P.malariae
![Page 7: Malaria - Year 3 - 2009-10 Rumala](https://reader034.vdocument.in/reader034/viewer/2022051108/545dc78eb1af9f2d0a8b4dc0/html5/thumbnails/7.jpg)
![Page 8: Malaria - Year 3 - 2009-10 Rumala](https://reader034.vdocument.in/reader034/viewer/2022051108/545dc78eb1af9f2d0a8b4dc0/html5/thumbnails/8.jpg)
PREPATENT PERIOD:
Interval between infection and demonstration of parasites
INCUBATION PERIOD
Interval between infection and clinical signs/symptoms
11-12 days
2-3 days more (about 2 weeks)
![Page 9: Malaria - Year 3 - 2009-10 Rumala](https://reader034.vdocument.in/reader034/viewer/2022051108/545dc78eb1af9f2d0a8b4dc0/html5/thumbnails/9.jpg)
PATHOPHYSIOLOGY
Pathology is due to erythrocytic cycle
A). Destruction of RBCs – haemolysis anaemiareleases endotoxins, malaria pigment
B). Host reaction: 1. IMMUNOPATHOLOGY
Balance between pro-inflammatory & anti-inflammatory cytokines
2. hyperplasia of RES system -splenomegaly & hepatomegaly
![Page 10: Malaria - Year 3 - 2009-10 Rumala](https://reader034.vdocument.in/reader034/viewer/2022051108/545dc78eb1af9f2d0a8b4dc0/html5/thumbnails/10.jpg)
Red Blood Cells rupture
Release parasite endotoxinsGlycosyl Phosphatidyl Inositol (GPI)
Activate MACROPHAGE-MONOCYTE system
Pro inflammatory Cytokines:TNF, interleukin-(IL-1), interferon-γ, IL-6, IL-8, macrophage colony-stimulating factor , lymphotoxin,superoxide and nitric oxide(NO)
Symptoms: FEVER, malaise, headache, nausea and vomiting, diarrhea, anorexia, body aches,
thrombocytopenia, immunosuppression, coagulopathy, CNS symptoms
![Page 11: Malaria - Year 3 - 2009-10 Rumala](https://reader034.vdocument.in/reader034/viewer/2022051108/545dc78eb1af9f2d0a8b4dc0/html5/thumbnails/11.jpg)
Plasmodial DNA presented by hemozoin
Release of proinflammatory
cytokines
Induce COX-2-upregulating
prostaglandins
FEVER
![Page 12: Malaria - Year 3 - 2009-10 Rumala](https://reader034.vdocument.in/reader034/viewer/2022051108/545dc78eb1af9f2d0a8b4dc0/html5/thumbnails/12.jpg)
after the infection gets established for about a week
MALARIA FEBRILE PAROXYSMSCLASSIC THREE STAGES :–
1. Cold stage – chills (15 min – 1hour)
2. Hot stage – High fever 106 ºF (2 - 6 hours)accompanied by head aches, vomiting, delirium,anxiety, restlessness
3. Sweating stage - profuse sweating and fever subsides (2-4 hours)
.
![Page 13: Malaria - Year 3 - 2009-10 Rumala](https://reader034.vdocument.in/reader034/viewer/2022051108/545dc78eb1af9f2d0a8b4dc0/html5/thumbnails/13.jpg)
FEVER with chills & rigors
Palpable SPLEEN
ANAEMIA Severe anaemia = leading causeof death in children with falciparum malaria.
![Page 14: Malaria - Year 3 - 2009-10 Rumala](https://reader034.vdocument.in/reader034/viewer/2022051108/545dc78eb1af9f2d0a8b4dc0/html5/thumbnails/14.jpg)
CLINICAL FEATURES
Depends on parasite species, parasitaemia, host immunity
1. FEVER - intermittent with chills & rigors
48h cycle- Pf, Pv, Po Tertian
72h cycle - Pm Quartan
1 3day 1 4
2. SPLENOMEGALY3. ANAEMIA
![Page 15: Malaria - Year 3 - 2009-10 Rumala](https://reader034.vdocument.in/reader034/viewer/2022051108/545dc78eb1af9f2d0a8b4dc0/html5/thumbnails/15.jpg)
D 1 2 3 4 5 6 1 2 3 4 5 6 1 2 3 4 5 6 7 8
P falciparum P vivax , P ovale P malariae
Fever patterns in malaria
tertian periodicity uncommon in primary attack of Pf
Tertian Quartan
![Page 16: Malaria - Year 3 - 2009-10 Rumala](https://reader034.vdocument.in/reader034/viewer/2022051108/545dc78eb1af9f2d0a8b4dc0/html5/thumbnails/16.jpg)
ANAEMIA normocytic, normochromic
(1). Major mechanism = haemolysis of parasitized cells
(2). Phagocytosis of non parasitized cellsSplenic clearance - rigidity of RBCs
immune clearance
(3). Dyserythropoiesis in bone marrow
![Page 17: Malaria - Year 3 - 2009-10 Rumala](https://reader034.vdocument.in/reader034/viewer/2022051108/545dc78eb1af9f2d0a8b4dc0/html5/thumbnails/17.jpg)
Haemoglobinutilization byparasite
Haem + parasite protein
Malaria pigment(haemozoin)
globin
Haemozoin induction of apoptosis in erythroid cells in the bone marrow
DYSERYTHROPOIETIC ANAEMIA
![Page 18: Malaria - Year 3 - 2009-10 Rumala](https://reader034.vdocument.in/reader034/viewer/2022051108/545dc78eb1af9f2d0a8b4dc0/html5/thumbnails/18.jpg)
Severe falciparum malaria
Gambian 3yr old cerebral malaria & opisthotonos
Dysconjugate (asymmetric)gaze in comatose Gambian child with cerebral malaria
![Page 19: Malaria - Year 3 - 2009-10 Rumala](https://reader034.vdocument.in/reader034/viewer/2022051108/545dc78eb1af9f2d0a8b4dc0/html5/thumbnails/19.jpg)
Infected RBCs get sequestered in capillaries ofvital organs eg. brain, liver, kidney
Mechanical obstruction of microcirculation= obstruction of small blood vessels eg. capillaries, post – capillary venules
P. falciparum – Pathophysiology of Severe Malaria
1. Cytoadherence of parasitized RBCs = RBCs with mature parasites stick to blood vessel walls in deep organs
SEQUESTRATION
![Page 20: Malaria - Year 3 - 2009-10 Rumala](https://reader034.vdocument.in/reader034/viewer/2022051108/545dc78eb1af9f2d0a8b4dc0/html5/thumbnails/20.jpg)
Interfere with microcirculation
1. Tissue hypoxia2. Nitric oxide [NO] release
2. Rosetting = Parasitized RBCs stick to uninfected RBCs
P. falciparum – Pathophysiology of Severe Malaria
3. Rigid parasitized RBCs get stuck in narrowed capillary lumen
![Page 21: Malaria - Year 3 - 2009-10 Rumala](https://reader034.vdocument.in/reader034/viewer/2022051108/545dc78eb1af9f2d0a8b4dc0/html5/thumbnails/21.jpg)
1. Cytoadherence (mainly) 2. Rosetting
3. Rigid parasitized RBCs
P. falciparum - Mechanisms of
Microcirculatory Obstruction
![Page 22: Malaria - Year 3 - 2009-10 Rumala](https://reader034.vdocument.in/reader034/viewer/2022051108/545dc78eb1af9f2d0a8b4dc0/html5/thumbnails/22.jpg)
(1).Rosetting (2). Endothelial Cytoadherence
VASCULAR OBSTRUCTION HYPOXIA
![Page 23: Malaria - Year 3 - 2009-10 Rumala](https://reader034.vdocument.in/reader034/viewer/2022051108/545dc78eb1af9f2d0a8b4dc0/html5/thumbnails/23.jpg)
Ischaemia &Tissue hypoxia
Cytoadherence , Rosetting & Rigid RBCs
Block capillaries & post capillary venules
NO = Nitric Oxide release
Oxidative damage to tissue
![Page 24: Malaria - Year 3 - 2009-10 Rumala](https://reader034.vdocument.in/reader034/viewer/2022051108/545dc78eb1af9f2d0a8b4dc0/html5/thumbnails/24.jpg)
Severe Malaria
• Impaired level ofconsciousness, COMA
• Convulsions• Generalized and
localizedneurological signs
Cerebral
Pathogenesis Clinical Features
Renal
• Acute tubular necrosis -sluggish blood flow and hypotension. • Intravascular haemolysis
• Oliguria• Haemoglobinuria• Acute Renal Failure [ARF]
Sluggish flow caused bysticky knobs on parasitizedredcells leading to stagnant
hypoxia and vascular damage.
![Page 25: Malaria - Year 3 - 2009-10 Rumala](https://reader034.vdocument.in/reader034/viewer/2022051108/545dc78eb1af9f2d0a8b4dc0/html5/thumbnails/25.jpg)
Severe Malaria: Common Clinical Manifestations 2 Pathogenesis Clinical Features
Increased pulmonarycapillary permeability
• Cough
• Pulmonary oedema [ARDS]
• Bronchopneumoni
a
• Elevated serum enzyme levels • Prolonged prothrombin time
Jaundice (mainly haemolytic) Bleeding
Respiratory
Hepatic
![Page 26: Malaria - Year 3 - 2009-10 Rumala](https://reader034.vdocument.in/reader034/viewer/2022051108/545dc78eb1af9f2d0a8b4dc0/html5/thumbnails/26.jpg)
Severe Malaria: Common Clinical Manifestations 3
BLOOD Severe anaemia – Hb < 5g/dlHypoglycaemiaAcidaemia
Shock Disseminated Intravascular Circulation [DIC]
Multiple Organ Dysfunction [MODS]
![Page 27: Malaria - Year 3 - 2009-10 Rumala](https://reader034.vdocument.in/reader034/viewer/2022051108/545dc78eb1af9f2d0a8b4dc0/html5/thumbnails/27.jpg)
1. Impairment of consciousness
Glasgow Coma Scale [adults] & Blantyre Scale [children]
2. Prostration – inability to sit unassisted in a child.
In infant not old enough to sit, inability to feed
[on examination - not just told in history]
3. Hyperparasitaemia >4% in non-immune [SL]
SEVERE MALARIA – 2000 WHO
Treat any patient as SEVERE MALARIA if physician is worried about Signs & Symptoms
BUT
![Page 28: Malaria - Year 3 - 2009-10 Rumala](https://reader034.vdocument.in/reader034/viewer/2022051108/545dc78eb1af9f2d0a8b4dc0/html5/thumbnails/28.jpg)
Severe Malaria
![Page 29: Malaria - Year 3 - 2009-10 Rumala](https://reader034.vdocument.in/reader034/viewer/2022051108/545dc78eb1af9f2d0a8b4dc0/html5/thumbnails/29.jpg)
Cerebral malaria -P falciparum
Africa - cerebral malaria common in children (6m to 3 yrs) high mortality - survivors, 10% have neurological sequelae
![Page 30: Malaria - Year 3 - 2009-10 Rumala](https://reader034.vdocument.in/reader034/viewer/2022051108/545dc78eb1af9f2d0a8b4dc0/html5/thumbnails/30.jpg)
Brain in cerebral malaria-autopsy specimen
perivascular haemorrhage
Parasitized RBCs filling venules/capillaries
![Page 31: Malaria - Year 3 - 2009-10 Rumala](https://reader034.vdocument.in/reader034/viewer/2022051108/545dc78eb1af9f2d0a8b4dc0/html5/thumbnails/31.jpg)
Liver in chronic malaria: dark colour is due to malarial pigment in macrophages
ANAEMIA in recurrent malaria
• hypersplenism• severe dyserythropoeisis - ineffective
erythropoeisis in bone marrow
![Page 32: Malaria - Year 3 - 2009-10 Rumala](https://reader034.vdocument.in/reader034/viewer/2022051108/545dc78eb1af9f2d0a8b4dc0/html5/thumbnails/32.jpg)
HAEMOGLOBINURIA (blackwater fever)
often due to G6PD deficiency & oxidant drugs eg. Primaquine
quinine therapy - immune lysis
Intravascular haemolysis
![Page 33: Malaria - Year 3 - 2009-10 Rumala](https://reader034.vdocument.in/reader034/viewer/2022051108/545dc78eb1af9f2d0a8b4dc0/html5/thumbnails/33.jpg)
Post-malaria neurological syndromes
Following cerebral malaria <than in other encephalopathies – 3% in
adults & 10-20% in childrenHemiparesis, cortical blindness, tremor,
cranial N palsy?subtle persistent cognitive/behavioural
effects
2-3 wks after P vivax uncomplicated malaria. Self limiting – few wks
Cerebellar Ataxia in Sri Lanka
![Page 34: Malaria - Year 3 - 2009-10 Rumala](https://reader034.vdocument.in/reader034/viewer/2022051108/545dc78eb1af9f2d0a8b4dc0/html5/thumbnails/34.jpg)
Hyperreactive malarial splenomegaly syndrome(Tropical splenomegaly syndrome)
massive spleens seen in endemic areas
Overproduction of polyclonal IgM immune response
![Page 35: Malaria - Year 3 - 2009-10 Rumala](https://reader034.vdocument.in/reader034/viewer/2022051108/545dc78eb1af9f2d0a8b4dc0/html5/thumbnails/35.jpg)
Malaria in Children
Severe Pf – rapid progression <1d feverP/CComaConvulsionsAcidosisHypoglycaemiaSevere anaemia
High risk of dying - ifRespiratory distress (acidotic breathing)Deep coma
![Page 36: Malaria - Year 3 - 2009-10 Rumala](https://reader034.vdocument.in/reader034/viewer/2022051108/545dc78eb1af9f2d0a8b4dc0/html5/thumbnails/36.jpg)
Malaria in Pregnancy
Areas with UNSTABLE Malaria (SL)Higher maternal mortality
& fetal lossMOTHER
oSevere anaemiaoAcute pulmonary
oedemaoHypoglycaemia
BABYoPremature births oLow Birth Weight Higher Neonatal Mortality
![Page 37: Malaria - Year 3 - 2009-10 Rumala](https://reader034.vdocument.in/reader034/viewer/2022051108/545dc78eb1af9f2d0a8b4dc0/html5/thumbnails/37.jpg)
RELAPSE OR RECRUDESCENCE?Reappearance of clinical symptoms following a period of being well
Recrudescence: 2- 4 weeks ‘specially in Pf
Due to presence of asexual blood stages that are not cleared - Inadequate treatment or drug
resistance
Relapse: 3- 6 weeks - Pv, Po
Due to hypnozoite activation merozoites
>% hypnozoites - relapses over longer term
![Page 38: Malaria - Year 3 - 2009-10 Rumala](https://reader034.vdocument.in/reader034/viewer/2022051108/545dc78eb1af9f2d0a8b4dc0/html5/thumbnails/38.jpg)
Clinical symptoms
parasitiaemia
subpatent
Liver schizogony-hypnozoites
Recrudescence & Relapse
Fever threshold
Microscopic threshold
Recrudescence Relapse 3-6 wks later
1st attack
![Page 39: Malaria - Year 3 - 2009-10 Rumala](https://reader034.vdocument.in/reader034/viewer/2022051108/545dc78eb1af9f2d0a8b4dc0/html5/thumbnails/39.jpg)
MALARIA ENDEMICITYSTABLE OR UNSTABLE TRANSMISSION
Hyper/holo endemic High anopheline biting
frequency Severe malaria in
6 months -3 yrs age Older – asymptomatic
parasitaemic [PREMUNITION]
Pregnancy – severe
malaria Spleen rate .50% in
children 2-9yrs
UNSTABLE MALARIA[Sri Lanka,Thailand, Cambodia]
Meso / hypoendemic
Severe malaria in all ages
Cerebral malaria > common
Spleen rate in children <50%
STABLE MALARIA [AFRICA]
![Page 40: Malaria - Year 3 - 2009-10 Rumala](https://reader034.vdocument.in/reader034/viewer/2022051108/545dc78eb1af9f2d0a8b4dc0/html5/thumbnails/40.jpg)
Laboratory diagnosis
Diagnosis confirmed by finding parasites/productsin blood using microscopy/ Antigen detection RDTs
1. Microscopy - thin /thick blood film x3 (if –ve repeat 12-24h)
THICK FILM (3-5l) – Very Sensitive Limit of detection 10-20 p/l =0.002% parasitaemia
THIN FILM (1l) - accurate species identification
2. Antigen detection - parasite derived products - proteinsenzymes
3. PCR – identify DNA (for research only)
![Page 41: Malaria - Year 3 - 2009-10 Rumala](https://reader034.vdocument.in/reader034/viewer/2022051108/545dc78eb1af9f2d0a8b4dc0/html5/thumbnails/41.jpg)
In falciparum malaria- peripheral parasitaemia could underestimate the total parasite burden
The parasites causing the clinical symptoms are SEQUESTERED in the capillaries of deep organsie. microvascular circulation
In synchronous cycles, peripheral parasitaemia could even be negative
Repeat blood films daily – 3 consecutive days
![Page 42: Malaria - Year 3 - 2009-10 Rumala](https://reader034.vdocument.in/reader034/viewer/2022051108/545dc78eb1af9f2d0a8b4dc0/html5/thumbnails/42.jpg)
42
Microscopy – identify parasite
Thin & Thick film x3 Consecutive daysGOLD STANDARD
THICK FILM(3-5 l)
Very SensitiveLimit of detection 10-20 p/l
Can quantify against WBCs
THIN FILM(1l) Accurate species identification
![Page 43: Malaria - Year 3 - 2009-10 Rumala](https://reader034.vdocument.in/reader034/viewer/2022051108/545dc78eb1af9f2d0a8b4dc0/html5/thumbnails/43.jpg)
43
Disadvantages1. Need trained experienced personnel2. Can’t do in field
Microscopy
Advantages1. Less costly2. High sensitivity3. Can quantify
![Page 44: Malaria - Year 3 - 2009-10 Rumala](https://reader034.vdocument.in/reader034/viewer/2022051108/545dc78eb1af9f2d0a8b4dc0/html5/thumbnails/44.jpg)
44
ANTIGEN DETECTIONRAPID DIAGNOSTIC TESTS [RDTs] Dipstick/card methods
1. Most useful commercial tests detectingBOTH Pf + Pv
Detects parasite Lactate dehydrogenase ( pLDH)depends on LIVE parasitesCAN USE TO TEST DRUG RESISTANCE
![Page 45: Malaria - Year 3 - 2009-10 Rumala](https://reader034.vdocument.in/reader034/viewer/2022051108/545dc78eb1af9f2d0a8b4dc0/html5/thumbnails/45.jpg)
2. RDTs – sensitivity is low(won’t detect below 100 – 200 parasites/μl)
45
ANTIGEN DETECTIONRAPID DIAGNOSTIC TESTS [RDTs]
WHO malaria RDT performance evaluation - Round 2
1. High cost
Disadvantages
Advantages1. Easy to do in field2. Don’t need trained persons
![Page 46: Malaria - Year 3 - 2009-10 Rumala](https://reader034.vdocument.in/reader034/viewer/2022051108/545dc78eb1af9f2d0a8b4dc0/html5/thumbnails/46.jpg)
![Page 47: Malaria - Year 3 - 2009-10 Rumala](https://reader034.vdocument.in/reader034/viewer/2022051108/545dc78eb1af9f2d0a8b4dc0/html5/thumbnails/47.jpg)
The leaves of Artemisia annua,
(China) are the source of artemisinin
Cinchona (Peru) – Quinine
Anti - malarials
![Page 48: Malaria - Year 3 - 2009-10 Rumala](https://reader034.vdocument.in/reader034/viewer/2022051108/545dc78eb1af9f2d0a8b4dc0/html5/thumbnails/48.jpg)
Malaria Treatment in Sri Lanka
Vivax malaria
1. Chloroquine – blood schizonticide
2. Primaquine – Kills
hypnozoites &
gametocytes
Falciparum MalariaCombination therapy to limit Development of drug resisitanceCO-ARTEMETHER[Artemether & Lumefantrine]& Primaquine
Severe Pf – Quinine
![Page 49: Malaria - Year 3 - 2009-10 Rumala](https://reader034.vdocument.in/reader034/viewer/2022051108/545dc78eb1af9f2d0a8b4dc0/html5/thumbnails/49.jpg)
Pregnant women in 1st trimester
Exclusively breastfeeding
Children weighing < 5 kg
‘Coartem’ is contraindicated for:-
Treatment = Quinine
![Page 50: Malaria - Year 3 - 2009-10 Rumala](https://reader034.vdocument.in/reader034/viewer/2022051108/545dc78eb1af9f2d0a8b4dc0/html5/thumbnails/50.jpg)
ANTIMALARIAL RESISTANCE
DEFINITION
“Ability of a parasite strain to survive or multiply
in spite of administration of a drug at usual
or higher than usual dose.
( where drug failure due to defective intake /absorption / metabolism has been excluded)”
P falciparum –Multi Drug Resistance (MDR) – combination therapy
P vivax - resistance to chloroquine in a few areas
RESISTANCE 3 grades :R1 (low grade) R ll (high) R lll (no response)
![Page 51: Malaria - Year 3 - 2009-10 Rumala](https://reader034.vdocument.in/reader034/viewer/2022051108/545dc78eb1af9f2d0a8b4dc0/html5/thumbnails/51.jpg)
P.falciparum – map of chloroquine resistance
![Page 52: Malaria - Year 3 - 2009-10 Rumala](https://reader034.vdocument.in/reader034/viewer/2022051108/545dc78eb1af9f2d0a8b4dc0/html5/thumbnails/52.jpg)
Assessment of Therapeutic Response to Anti-malarials
(1) Parasite Clearance Time (PCT)
Time between beginning the anti-malarial treatment and the first –ve blood film
(2) Fever Clearance Time (FCT)Time from beginning anti- malarial treatment until the patient is apyrexial [no fever]
![Page 53: Malaria - Year 3 - 2009-10 Rumala](https://reader034.vdocument.in/reader034/viewer/2022051108/545dc78eb1af9f2d0a8b4dc0/html5/thumbnails/53.jpg)
Prevention & Control of Malaria
Interrupt transmission @ different stages
1. MAN
3. PARASITE
2. VECTOR
A
C
B
![Page 54: Malaria - Year 3 - 2009-10 Rumala](https://reader034.vdocument.in/reader034/viewer/2022051108/545dc78eb1af9f2d0a8b4dc0/html5/thumbnails/54.jpg)
A. Prevent Man-Vector Contact / Reduce Vector Population
most useful strategies Insecticide impregnated bed nets Residual insecticide spraying ofhouses
Prevention & Control of Malaria
B. Reduce Parasite Population Treatment of patients – Gametocytocides (Primaquine) also to prevent transmission
![Page 55: Malaria - Year 3 - 2009-10 Rumala](https://reader034.vdocument.in/reader034/viewer/2022051108/545dc78eb1af9f2d0a8b4dc0/html5/thumbnails/55.jpg)
Still experimental Multistage, multi component -
anti sporozoite, liver stages, merozoite,ring infected erythrocytes
Transmission blocking – anti gametocyte
Anti disease not anti parasitic –So as not to prevent infection & reduce natural immunity = Premunition
DNA vaccines
Vaccines
![Page 56: Malaria - Year 3 - 2009-10 Rumala](https://reader034.vdocument.in/reader034/viewer/2022051108/545dc78eb1af9f2d0a8b4dc0/html5/thumbnails/56.jpg)
Prevention & Control of Malaria in SL
Ministry of Health – Anti Malaria Campaign ELIMINATION of Malaria transmission in SL by 2015
56
200,000 cases in 2000
23 in 2012 (99.99% reduction)
2012 lowest number of malaria cases since
1963
Dramatic reduction of microscopically confirmed case load
http://www.malariacampaign.gov.lk
![Page 57: Malaria - Year 3 - 2009-10 Rumala](https://reader034.vdocument.in/reader034/viewer/2022051108/545dc78eb1af9f2d0a8b4dc0/html5/thumbnails/57.jpg)
57
Ministry of Health – Anti Malaria CampaignGoal - ELIMINATION of Malaria transmission in SL
by 2015
Prevention & Control of Malaria in SL
200,000 cases in 2000
23 in 2012 (99.99% reduction) 2012 lowest number of malaria cases since 1963.
Dramatic reduction of microscopically confirmed case load
http://www.malariacampaign.gov.lk
Most detected by1. Activated Passive Case
Detection (APCD) – hospitals in endemic area
also2. Active Case Detection
(ACD) and Mobile malaria clinics – home visits
![Page 58: Malaria - Year 3 - 2009-10 Rumala](https://reader034.vdocument.in/reader034/viewer/2022051108/545dc78eb1af9f2d0a8b4dc0/html5/thumbnails/58.jpg)
MALARIA DAY WALK
Global fund - grant to eliminate malaria in SL given to TEDHA= Tropical and Environmental Diseases and Health Associates
![Page 59: Malaria - Year 3 - 2009-10 Rumala](https://reader034.vdocument.in/reader034/viewer/2022051108/545dc78eb1af9f2d0a8b4dc0/html5/thumbnails/59.jpg)
![Page 60: Malaria - Year 3 - 2009-10 Rumala](https://reader034.vdocument.in/reader034/viewer/2022051108/545dc78eb1af9f2d0a8b4dc0/html5/thumbnails/60.jpg)
Clinical features of severe falciparum malaria include
A. Severe anaemia
B. Acute pulmonary oedema
C. Hypoglycaemia
D. Coma
E. Convulsions
T=ABCDE
![Page 61: Malaria - Year 3 - 2009-10 Rumala](https://reader034.vdocument.in/reader034/viewer/2022051108/545dc78eb1af9f2d0a8b4dc0/html5/thumbnails/61.jpg)
References
Look at these websites
• World health Organization: WHO - www.who.int/
• Centers for Disease Control and Prevention (cdc) website : www.cdc.gov/
Books
1. Manson’s Tropical Diseases – 21st Ed
2. Worms & Human Disease – Ralph Muller & Derek Wakelin
• White NJ. Plasmodium knowlesi: the fifth human malaria parasite.Clinical Infectious Diseases 2008 Jan 15;46(2):172-3.
• Polrat Wilairatana et al Management of Plasmodium knowlesi malaria without PCR confirmation. http://www.tm.mahidol.ac.th/